Hjem › Alpha-1-antitrypsinmangel › Texas
Alpha-1-antitrypsinmangel kliniske forsøg i Texas
4 studier for Alpha-1-antitrypsinmangel søger deltagere på steder i Texas.
Officiel studietekst (engelsk)
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 109, Dallas
RekruttererFase 3
Alder 18 til 80 · Alle køn · Opdateret 11. aug. 2026 · NCT07555483Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein
- Texoma Liver Center, Denison
- Baylor College of Medicine Medical Center, Houston
- The Texas Liver Institute, San Antonio
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 13. maj 2026 · NCT05677971Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)
- Texas Liver Institute American Research Corporation, San Antonio
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 5. mar. 2026 · NCT06165341A Study of KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency
- Renovatio Clinical, The Woodlands
RekruttererFase 1
Alder 18 til 70 · Alle køn · Opdateret 22. jul. 2025 · NCT06049082Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.